title: Changes in direct-to-consumer pharmaceutical advertising following shifts from prescription-only to over-the-counter status.
authors.affiliation: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts, USA. greene@jhmi.edu
authors.forename: Jeremy A
authors.initials: JA
authors.lastname: Greene
authors.forename: Niteesh K
authors.initials: NK
authors.lastname: Choudhry
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Kesselheim
authors.forename: Troyen A
authors.initials: TA
authors.lastname: Brennan
authors.forename: William
authors.initials: W
authors.lastname: Shrank
mesh_terms: D000329:Advertising / Q000592:standards* / Q000639:trends; D000075202:Contraindications; D004345:Drug Industry; D016568:Drugs, Generic; D006801:Humans; D004366:Nonprescription Drugs / Q000009:adverse effects; D055553:Prescription Drugs / Q000009:adverse effects; D009626:Terminology as Topic; D014481:United States; D014485:United States Federal Trade Commission; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic; D004366:Nonprescription Drugs; D055553:Prescription Drugs